1.9 C
New York
Tuesday, March 3, 2026

IBD Stock Of The Day Lilly Surges As Diabetes Drug Sales Rocket 652%

Eli Lilly $25.83 4.66% 75% IBD Stock Analysis Stock is retaking the 50-day line Composite Rating Industry Group Ranking Emerging Pattern A stock may pull …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

149,460FansLike
396,312FollowersFollow
2,650SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x